Literature DB >> 18582258

Medication-related patient safety incidents in critical care: a review of reports to the UK National Patient Safety Agency.

A N Thomas1, U Panchagnula.   

Abstract

We reviewed all patient safety incidents reported to the UK National Patient Safety Agency between 1st August 2006 and 28th February 2007 from intensive care or high dependency units. Incidents involving medications were then categorised. 12 084 incidents were submitted from 151 organisations (median 40, range 1-634/organisation). 2428 incidents were associated with medication use involving 355 different drugs, most commonly morphine (207 incidents), gentamicin (190 incidents) and noradrenaline (133 incidents). Noradrenaline (55 incidents of harm) and insulin (48 incidents of harm) were most commonly associated with patient harm. Sixty-one percent of medication incidents were associated with drug administration and 26% with prescription. Two hundred and eighty-seven medication incidents caused temporary harm and 43 more than temporary harm. Five per cent of medication incidents were associated with staff communication during transfer from theatre or recovery. Categorisation of medication-associated incidents has allowed us to suggest changes to improve the reporting of incidents and to improve medication safety.

Entities:  

Mesh:

Year:  2008        PMID: 18582258     DOI: 10.1111/j.1365-2044.2008.05485.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  9 in total

1.  Voluntarily reported prescribing, monitoring and medication transfer errors in intensive care units in The Netherlands.

Authors:  B E Bosma; N G M Hunfeld; E Roobol-Meuwese; T Dijkstra; S M Coenradie; A Blenke; W Bult; P H G J Melief; M Perenboom-Van Dixhoorn; P M L A van den Bemt
Journal:  Int J Clin Pharm       Date:  2020-08-19

2.  Simple prescribing errors and allergy documentation in medical hospital admissions in Australia and New Zealand.

Authors:  Lorna Barton; Judith Futtermenger; Yash Gaddi; Angela Kang; Jon Rivers; David Spriggs; Paul F Jenkins; Campbell H Thompson; Josephine S Thomas
Journal:  Clin Med (Lond)       Date:  2012-04       Impact factor: 2.659

3.  A Mixed-Methods Analysis of Medication Safety Incidents Reported in Neonatal and Children's Intensive Care.

Authors:  Anwar A Alghamdi; Richard N Keers; Adam Sutherland; Andrew Carson-Stevens; Darren M Ashcroft
Journal:  Paediatr Drugs       Date:  2021-04-08       Impact factor: 3.022

Review 4.  Magnitude of error: a review of wrong dose medication incidents reported to a UK hospital voluntary incident reporting system.

Authors:  Gillian F Cavell; Deepal Mandaliya
Journal:  Eur J Hosp Pharm       Date:  2019-08-21

5.  Incident reporting in post-operative patients managed by acute pain service.

Authors:  Syeda Fauzia Hasan; Mohammad Hamid
Journal:  Indian J Anaesth       Date:  2015-12

Review 6.  Systematic literature review of hospital medication administration errors in children.

Authors:  Ahmed Ameer; Soraya Dhillon; Mark J Peters; Maisoon Ghaleb
Journal:  Integr Pharm Res Pract       Date:  2015-11-05

Review 7.  Dosing errors of empirical antibiotics in critically ill patients with severe sepsis or septic shock: A prospective observational study.

Authors:  Hasan M Al-Dorzi; Abdullah T Eissa; Raymond M Khan; Shmeylan A Al Harbi; Tarek Aldabbagh; Yaseen M Arabi
Journal:  Int J Health Sci (Qassim)       Date:  2019 Jul-Aug

8.  Glycemic control and diabetes management in hospitalized patients in Brazil.

Authors:  Edson Duarte Moreira; Patricia Carvalho Balthazar Silveira; Raimundo Celestino Silva Neves; Clodoaldo Souza; Zaira Onofre Nunes; Maria da Conceição C Almeida
Journal:  Diabetol Metab Syndr       Date:  2013-10-18       Impact factor: 3.320

9.  Latent Safety Threats and Countermeasures in the Operating Theater: A National In Situ Simulation-Based Observational Study.

Authors:  Jennifer A Long; Craig S Webster; Timothy Holliday; Jane Torrie; Jennifer M Weller
Journal:  Simul Healthc       Date:  2022-02-01       Impact factor: 1.929

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.